Dr. Lacy’s role on the biomedical company’s board includes advising Biomerica on the commercialization of Biomerica InFoods Technology platform products such as its irritable bowel syndrome product, according to a Jan. 10 news release.
Dr. Lacy has written more than 225 peer-reviewed articles and was the former co-editor-in-chief of the American Journal of Gastroenterology.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
